阿(a)斯利(li)康通(tong)過(guo)制(zhi)造(zao)供應鏈(lian)(lian)(lian)、新藥(yao)(yao)創(chuang)(chuang)新鏈(lian)(lian)(lian)、產業生態(tai)鏈(lian)(lian)(lian)、創(chuang)(chuang)新出海鏈(lian)(lian)(lian)、可(ke)持續(xu)發展鏈(lian)(lian)(lian)5大(da)板塊全面展示深耕中國30多年來取得的(de)成果。還攜手(shou)阿(a)里健康、默克、諾和諾德共同發起"醫藥(yao)(yao)企(qi)業藥(yao)(yao)品(pin)流通(tong)資(zi)料(liao)電子化(hua)行(xing)動(dong)倡議"，通(tong)過(guo)將藥(yao)(yao)品(pin)流通(tong)過(guo)程中所(suo)需(xu)的(de)紙(zhi)質(zhi)資(zi)料(liao)進行(xing)合規的(de)電子化(hua)，減(jian)少紙(zhi)張(zhang)消耗，助力低(di)碳、高效、可(ke)持續(xu)醫療。（美通(tong)社）